-The structures of two epidemiologic parameters are explored. One, the "etiologic fraction." relates to markers of increased risk, and it is the proportion of disease attributable to the marker and/or to factors associated with it. The other, the "prevented fraction," is the equivalent of this for a marker of reduced risk. It is shown that both parameters depend-in different ways-on the frequency of the marker among cases of the disease, and on the "standardized morbidity ratio" for those with the marker. Point estimation of these parameters is often straight-forward, particularly in case-control studies.
The quantitation of the disease-producing role of an etiologic factor is pertinent not only from the scientific point of view but for the planning of intervention programs as well. One appropriate parameter for this is the proportion of the disease that is attributable to the factor at issue. Thus, when contemplating coronary heart disease (CHD) control through anti-smoking programs one wonders what fraction of CHD might be due to smoking. Introduced two decades ago (1) , this parameter has -rather inexplicably-received little attention from epidemiologists (2, 3) .
The preventive role of a protective factor, or the preventive success of an implemented program of intervention, could be expressed in terms of an analogous parameter: the fraction of the disease prevented by the factor or program. As a population parameter, this measure, too, has remained without the attention it seems to warrant.
In this paper, previous results as to the structures of these parameters are reiterated and then adjusted to take account of the usual circumstances which involve confounding and also nonuniformity of risk ratio ("relative risk" (RR)) among strata of the confounding factor(s).
ETIOLOGIC FRACTION RELATED TO A MARKER OF INCREASED RISK
The proportion of the total load of a disease that is attributable to a given factor is that fraction of the disease which would not have occurred had the factor been absent from the population. This parameter may be regarded as the "fraction of etiology" or "etiologic fraction" attributable to the factor.
In nonexperimental epidemiologic research it would usually be pretentious to offer any specific estimate of the etiologic 325 fraction attributable to a given marker of increased risk-as if confounding by extraneous factors were well under control. Instead, it would be prudent to think in terms of the etiologic fraction related to the marker-with certain, though not all, confounding factors under control. Were it known that no material confounding is left, then the observable etiologic fraction would be attributable to that risk marker itself; otherwise that fraction is, at least in part, due to other factors associated with the risk marker at issue.
All-or-none marker of increased risk
Previous results. An expression for the structure of the etiologic fraction (EF) related to an all-or-none marker of increased risk was first developed by Levin (1) . For those with the marker this fraction was taken as
where RR, is the risk ratio for those with the marker, with those who do not exhibit the marker as the referent (and characterized by RR 0 = 1). By the same token, for the referent category, EF 0 = 0. For the overall EF, Levin gave the expression
(RR, > l), where SF, is the source (population) fraction of people with the marker. These results were also derived by Cole and MacMahon (2) .
An alternate formulation of the EF was offered by Miettinen (4) and Panayotou et al. (5) : 
(RR, > 1) Proposed modifications. These formulas require modification to encompass the usual case which involves not only confounding but also nonuniformity of the RR among strata of the confounding factor(s).
For those with the marker, the etiologic fraction (EF,) expresses what proportion of the "crude" (observable) risk (CR,) is in excess of the "expected" risk (ER,) which would result from the referent risks (of those without the marker) obtaining, within categories of the confounding factors), among the higher-risk people (those with the marker) as well. Thus, for the higher-risk category of the risk indicator,
where SMR, is the "standardized morbidity (mortality) ratio" in its customary definition (6) .
By the same token, the generalization of formula 2 rests on the recognition that in general (6) (CR > ER) where CR is the "crude" (observable) risk in the population at issue, and ER is the "expected" risk for it-the "expectation" corresponding to the rates of the referent category of the risk indicator within each stratum of the confounding factor(s (SMR, > 1) Comparison of formula 2 to this result shows that, in the previous formula, the RR in both the numerator and the denominator should be the "crude" one, and that in the numerator-which has to do with cases in excess of the "expectation"-the referent for the "crude" RR should not generally be taken as unity, but, naturally enough, as CRRJSMR,, which is the RR the controlled confounding alone would produce in the absence of control (6) . For comparability with formulations involving the distribution of cases, rather than of the source population, according to the risk indicator (formulas 4 and 9) it is of interest to recast formula 7 as
(SMR, > 1) The adjustment required for generality in the formula based on case distribution (formula 4) is simply to use SMR, in place of RR,. Thus, formula 4 should be superseded by
{SMR, > 1) This expression must be interchangeable with formulas 7 and 8. This implies that, in general, CF, = SF, x CRR,/ (10) (SF 0 + SF, x CRR,). This equivalence is obvious as such. So is the relative simplicity of formula 9 as compared to formula 8.
Polytomous marker of increased risk Previous result.
A generalization of formula 4 to the simplest case of a multicategory indicator of risk has been given by Miettinen (7) . This simple case is the one where there is a reasonably nonarbitrary specification of the referent category, and where the overall risk in all other categories is at least as high as would be "expected" on the basis of the confounding-factorspecific risks in the referent. An example of this is smoking as an indicator of CHD risk, with the referent category taken as those who never smoked. The formula that was employed for this case is (SMR, > 1 for all 0 Alternative. An expression which involves the distribution of the entire source population (rather than of cases only) may be derived from formula 11 by the use of the relationship in equation 10. This alternative to formula 12 is still including the referent in the range of the summation. This expression is algebraically identical to formula 12. Thus, in the general case (where possibly some SMR t < 1) EF may be defined even if EF, cannot be defined for some categories of the risk indicator, and when the EF is defined, the expression of its structure in terms of SMR's need not be modified when having SMR, < 1 (EF t undefined) for some of the categories.
A further problem arises in the case of an arbitrary referent. Consider, as an example, the hypertension-related fraction of the etiology of CHD. The risk of CHD is a monotone increasing function of diastolic blood pressure. Thus, whereas diastolic hypertension presumably means diastolic pressure above "normal" values, "normalcy" eludes rational definition. Suppose one arbitrarily chooses the level of 75-84 mm Hg as the referent category. It would then be rather meaningless to construct the parameter as in formulas 12 and 14, including in the summation the relatively protected category of under 75 mm Hg. The summation would, instead, be confined to blood pressure categories in the range of 85 mm Hg or more. The interpretation of this parameter, under the assumption of no confounding, is not simply that of the fraction of CHD etiology attributable to diastolic blood pressure being 85 mm Hg or more; it is to be borne in mind that the implied alternative for those high pressures is the 75-84 mm Hg range and not the broad and relatively nonhomogeneous range of under 85 mm Hg.
Composite marker of increased risk
The EF related to an aggregate of markers of increased risk does not differ in principle from that related to a single one, because the various combinations of the levels of the component indicators can be construed as categories of a single-though composite-indicator of risk. For example, when dealing with the aggregate of cigarette-smoking, hypertension and hypercholesterolemia in relation to CHD, the referent category of a (single) composite indicator of risk might most naturally be taken as that characterized jointly by no cigarette-smoking, normotension and normocholesterolemia (whatever the definitions).
If two or more indicators of risk are statistically independent and have associated with them etiologic influences which are biologically independent, the overall EF for the composite indicator can be expressed in terms of the component EF's:
(statistical and biological independence)
where EF a is the EF related to marker "A," etc. By the same token, under statistical independence, departures from that equality imply either synergy or antagonismsynergy if When dealing with a preventive intervention, or with any (person) characteristic or (environmental) exposure which protects against the disease at issue, the equivalent of the EF is, as already pointed out, the prevented fraction (of the disease) related to the particular indicator of protection. It is the fraction of the potential total load of the disease which is prevented by the marker of protection and/or factors associated with it.
It appears that no expression for the structure of this parameter has been offered.
All-or-none marker of decreased risk
In the case of a dichotomous indicator of protection, an expression for the prevented fraction (PF) specific for the lower-risk category of the risk indicator is 
(cf. formula 9). Formulas 20 and 22 must be interchangeable just as the respective formulasfor EF were (formulas 8 and 9). And again, this interchangeability implies the relationship between CF t and SF X given in equation 10.
Polytomous and composite markers of decreased risk
The issues relating to the structure of the PF in the cases of polytomous and composite indicators of protection are quite analogous to those discussed in the context of EF.
For a polytomous indicator of protection, the key relationship is the counterpart of equation 12, namely PF = £, CF,* x (1 -SMR t ), A set of indicators whose related overall effect is preventive can again be treated as a single-though composite-indicator of protection analogously with a composite indicator of etiologic influence. With statistically independent components and (biologically) independent influences, the joint PF is   PF a , b ... = 1 -(1 -PF a )(l -PF b ) ...
(statistical and biological independence).
EST1MABILITY

Point estimation
From the above exposition of the structures of the etiologic and prevented fractions related to markers of increased and decreased risks, respectively, it is apparent that the point estimation of each parameter involves the estimation of two sets of component parameters, the case fractions (CF,'s) in the various categories of the risk indicator and the "standardized morbidity ratios" (SMfl/s) for those categories.
For the CF,'s one can use the respective sample values as long as the cases included in the study can be considered representative of cases in the source population. In case-control studies this is generally the aim and, more or less, the attained reality. Cohort studies may include electiveness as to the levels of the indicator of risk and, in particular, there tends to be health-related restrictions for inclusion in the study.
Point estimation of SMR t 's is, in principle, feasible not only in cohort studies but in case-control studies as well (6, 8) . In case-control studies, however, it is necessary to have reasonably large numbers of subjects from each stratum of the confounding factor(s). Thus, the computation of SMR estimates is not feasible in casecontrol studies with individual matching, and the practical alternative is simply to assume uniformity of the risk ratio and to use an appropriate estimate of that parameter (9) as a substitute for the SMR estimate.
Example. Data from a case-control study relating coffee consumption and myocardial infarction (MI) are shown in table 1 (10) . The estimation of the coffee-related etiologic fraction for MI depends only on the distribution of the cases by level of coffee consumption (case fractions at the different levels) together with the standardized morbidity ratios for those categories of exposure (cf. formulas 9 and 12). one to five cups per day and for those drinking at least six cups per day the estimates 5M&\ and 5Mfl, are the ratios of the observed numbers of cases in these categories, 302 and 67, respectively, to the estimates of their respective "expectations." The latter are accumulated from the strata, as follows. The stratum of 40-to 49-year-old males without history of MI contributes 8(911)/308 = 23.7 and 8(287)/308 = 7.5 to the two estimates of "expectations," respectively. The next stratum gives l(65)/35 = 1.9 and l(25)/35 = 0.7, respectively. Then, SMR t = 302/(23.7 + 1.9 + ...) = 302/185.1 = 1.63, and SMR 3 = 67/(7.5 + 0.7 + ...)= 67/30.6 = 2.19. Thus, were one to consider the cases to be representative of those in the source, and were one to ignore possible sources of confounding other than age, sex and history of MI, one would estimate that among those drinking one to five and those drinking at least six cups of coffee per day the proportions of Mi's attributable to coffee-drinking are (1.63 -D/1.63 = 39 per cent, and (2.19 -1)/2.19 = 54 per cent, respectively (cf. formula 5). Moreover, recalling the case fractions and continuing to entertain the assumptions, it could be estimated that, overall, a fraction of 0.69(0.39) + 0.15(0.54) = 35 per cent of all Mi's in the source population are attributable to coffee-drinking (cf. formula 12). If additional confounding remains, these are estimates of the fractions of Mi's related rather than attributable to coffeedrinking.
Interval estimation
The sampling variability of the above estimators poses a rather challenging problem. No results are available.
DISCUSSION
The proportion of a given disease attributable to a particular etiologic factor is obviously dependent not only on the risk of the disease among people with this factor relative to those without it (RRJ but also on the frequency (SFJ of this factor in the population from which the cases arise. With the total number of cases proportional to SF 0 + SF l x RR U the number attributable to the factor is proportional to SF, x (flfl, -1). Rewriting SF 0 + SF l x RR, as 1 + SF t x (flfl, -1) leads to the formula for etiologic fraction offered by Levin (1) and by Cole and MacMahon (2) (formula 2).
That the (natural) preoccupation with the frequency of the factor in the source population of cases may be replaced by its frequency among the cases themselves may not be immediately obvious. However, if among those in the source population who have the factor a fraction 2?F, of cases is attributable to the factor, then this fraction EF t of cases with the factor are attributable to the factor, while none of the cases without the factor are. This equivalence implies formulas 3 and 4.
As to the preventive fraction, intuition might suggest that this is nothing but a negative etiologic fraction, and that it could be thought of in terms of, say, formula 4 (with RR, < 1). However, the preventive fraction is the proportion of cases prevented by the factor among the totality of cases that would have developed in the absence of the protective factor, and it is thus necessary to replace the observable fraction of cases with the factor by that which it would have been in the hypothetical totality of cases (prevented and unprevented). Moreover, among those with the factor, the prevented fraction (formula 18) is not the absolute value for the etiologic fraction (formula 1).
In the generalization of these formulations to the usual case where confounding is to be allowed for and where the risk ratio varies over the categories of the confounding factor(s), it might be instructive to write the defining formulas for the etiologic and preventive fractions (formulas 6 and 19, respectively) as In these terms the overall etiologic and preventive fractions have structures similar to those of the corresponding parameters for those with the marker (formulas 5 and 18). However, this approach involves a certain generalization in the SMR concept: whereas it still is the "observed-to-expected" ratio, the referent is not necessarily confined to those exhibiting the risk marker at issue.
